Paolo Fusar-Poli

Anterior cingulate pathology in the prodromal stage of schizophrenia.

Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition.

Medicine and the arts. Brain Damage by Pink Floyd (1973). Commentary.

Egas Moniz (1875-1955), the father of psychosurgery.

Neural correlates of executive function and working memory in the 'at-risk mental state'.

Genetic vulnerability to affective psychopathology in childhood: a combined voxel-based morphometry and functional magnetic resonance imaging study.

Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.

Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis.

Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol.

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.

Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies.

Altered medial temporal activation related to local glutamate levels in subjects with prodromal signs of psychosis.

Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: longitudinal MRI-EEG study.

White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study.

Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis.

Reduced mismatch negativity predates the onset of psychosis.

Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies.

Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosis.

Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.

Images in psychiatry. Sabina Spielrein.

Editorial.

Episodic memory dysfunction in individuals at high-risk of psychosis: a systematic review of neuropsychological and neurofunctional studies.

Glutamate and psychosis risk.

Neurophysiological alterations in the prepsychotic phases.

Genetic vulnerability to psychosis and cortical function: epistatic effects between DAAO and G72.

Cannabis abuse and vulnerability to psychosis: targeting preventive services.

Economic impact of early detection and early intervention of psychosis.

Ethical implications for clinical practice and future research in "at risk" individuals.

Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis.

Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies.

Should attenuated psychosis syndrome be included in DSM-5?

Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studies.

Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk.

Alterations in white matter evident before the onset of psychosis.

At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk.

Cognitive functioning in prodromal psychosis: a meta-analysis.

Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence.

Why are psychiatric imaging methods clinically unreliable? Conclusions and practical guidelines for authors, editors and reviewers.

White matter pathology--an endophenotype for bipolar disorder?

Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences.

Whither the attenuated psychosis syndrome?

Effects of antipsychotics on dentate gyrus stem cell proliferation and survival in animal models: a critical update.

Efficacy and safety of second-generation long-acting injections in schizophrenia: a meta-analysis of randomized-controlled trials.

The psychosis high-risk state: a comprehensive state-of-the-art review.

Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis.

One century of Allgemeine Psychopathologie (1913 to 2013) by Karl Jaspers.

White matter alterations in early stages of schizophrenia: a systematic review of diffusion tensor imaging studies.

Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.

Prevalence of self-reported childhood abuse in psychosis: a meta-analysis of retrospective studies.

Potential reporting bias in fMRI studies of the brain.

Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users.

Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders.

Patients' and clinicians' attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis.

Functional brain networks before the onset of psychosis: A prospective fMRI study with graph theoretical analysis.

Multimodal voxel-based meta-analysis of structural and functional magnetic resonance imaging studies in those at elevated genetic risk of developing schizophrenia.

Dopaminergic basis of salience dysregulation in psychosis.

Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state.

Anisotropic kernels for coordinate-based meta-analyses of neuroimaging studies.

The impact of delivering GP training on the clinical high risk and first-episode psychosis on referrals and pathways to care.

Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention.

Neurofunctional maps of the 'maternal brain' and the effects of oxytocin: a multimodal voxel-based meta-analysis.

Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation.

Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies.

Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials.

Sensory gating deficits in the attenuated psychosis syndrome.

Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research.

Speed of Psychosis Progression in People at Ultra-High Clinical Risk: A Complementary Meta-analysis.

Modulation of motivational salience processing during the early stages of psychosis.

Duration of untreated psychosis and need for admission in patients who engage with mental health services in the prodromal phase.

Why are help-seeking subjects at ultra-high risk for psychosis help-seeking?

Hippocampal volume correlates with attenuated negative psychotic symptoms irrespective of antidepressant medication.

The Enduring Search for the Koplik Spots of Psychosis.

Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis.

At risk or not at risk? A meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction.

Ventral Striatal Activation During Reward Processing in Psychosis: A Neurofunctional Meta-Analysis.

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis.

Brain Diffusion Changes in Emerging Psychosis and the Impact of State-Dependent Psychopathology.

Prognosis of Brief Psychotic Episodes: A Meta-analysis.

Intensive community outreach for those at ultra high risk of psychosis: dilution, not solution.

Authors' reply.

Dysfunctional insular connectivity during reward prediction in patients with first-episode psychosis.

Altering the course of schizophrenia: progress and perspectives.

Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.

An initial investigation of abnormal bodily phenomena in subjects at ultra high risk for psychosis: Their prevalence and clinical implications.

Prison and Community Populations at Ultra-High Risk of Psychosis: Differences and Challenges for Service Provision.

Using neuroimaging to help predict the onset of psychosis.

Prevalence and implications of Truman symptoms in subjects at ultra high risk for psychosis.

Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis.

Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.

Structural Network Disorganization in Subjects at Clinical High Risk for Psychosis.

Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation.

Pattern of activation during delayed matching to sample task predicts functional outcome in people at ultra high risk for psychosis.

Deconstructing Pretest Risk Enrichment to Optimize Prediction of Psychosis in Individuals at Clinical High Risk.

Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies.

What Is an Attenuated Psychotic Symptom? On the Importance of the Context.

The Clinical High-Risk State for Psychosis (CHR-P), Version II.

Diagnostic and Prognostic Significance of Brief Limited Intermittent Psychotic Symptoms (BLIPS) in Individuals at Ultra High Risk.

Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders.

Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis.

Negative Psychosis Prevention Trials.

Age-related brain structural alterations as an intermediate phenotype of psychosis.

Why ultra high risk criteria for psychosis prediction do not work well outside clinical samples and what to do about it.

Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis.

Extending the Benefits of Indicated Prevention to Improve Outcomes of First-Episode Psychosis.

Formal thought disorder in people at ultra-high risk of psychosis.

Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.

A systematic review and meta-analysis of mental health service use in people who report psychotic experiences.

Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies.

Improving outcomes of first-episode psychosis: an overview.

People meeting ultra high risk for psychosis criteria in the community.

What causes psychosis? An umbrella review of risk and protective factors.

Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies.

Gamma band oscillations in the early phase of psychosis: A systematic review.

Semistructured Interview for Bipolar At Risk States (SIBARS).

Potential Reporting Bias in Neuroimaging Studies of Sex Differences.

Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventions.

Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.

Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust.

Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis.

Ten simple rules for conducting umbrella reviews.

Impact on the Onset of Psychosis of a Polygenic Schizophrenia-Related Risk Score and Changes in White Matter Volume.

Response to the commentary by Buoli et al., EURPSY-D-18-00265.

A Case of a College Student Presenting With Mild Mental Health Problems.

The Science of Prognosis in Psychiatry: A Review.

The relationship between ethnicity and service access, treatment uptake and the incidence of psychosis among people at ultra high risk for psychosis.

Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis.

Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services.

Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state.

Neurochemical effects of oxytocin in people at clinical high risk for psychosis.

Towards a framework for good outcome in people at clinical high risk for psychosis: A Delphi consensus study.

Real World Implementation of a Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk of Psychosis in Clinical Routine: Study Protocol.

Psychosis Polyrisk Score (PPS) for the Detection of Individuals At-Risk and the Prediction of Their Outcomes.

Transdiagnostic psychiatry: a systematic review.

Basic Self-Disturbances Related to Reduced Anterior Cingulate Volume in Subjects at Ultra-High Risk for Psychosis.

Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age.

Risk and protective factors for anxiety and obsessive-compulsive disorders: an umbrella review of systematic reviews and meta-analyses.

Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis.

Association of antidepressants with brain morphology in early stages of psychosis: an imaging genomics approach.

What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors.

Environmental risk factors and biomarkers for autism spectrum disorder: an umbrella review of the evidence.

Integrated Mental Health Services for the Developmental Period (0 to 25 Years): A Critical Review of the Evidence.

Development and Validation of a Dynamic Risk Prediction Model to Forecast Psychosis Onset in Patients at Clinical High Risk.

Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice.

Development of a Self-Administered Questionnaire to Detect Psychosis at High Altitude: The HAPSY Questionnaire.

TRANSD recommendations: improving transdiagnostic research in psychiatry.

Risk factors for posttraumatic stress disorder: An umbrella review of systematic reviews and meta-analyses.

Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review.

E-Clinical High Risk for Psychosis: Viewpoint on Potential of Digital Innovations for Preventive Psychiatry.

European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP).

Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes.

Clinical-learning versus machine-learning for transdiagnostic prediction of psychosis onset in individuals at-risk.

Specialized services for individuals at clinical high risk for psychosis target simultaneously adolescents and young adults.

SSRIs and autism: interpreting an umbrella review - Authors' reply.

Pan-London Network for Psychosis-Prevention (PNP).

Improving the Detection of Individuals at Clinical Risk for Psychosis in the Community, Primary and Secondary Care: An Integrated Evidence-Based Approach.

Psychotic experiences, psychiatric comorbidity and mental health need in the general population: a cross-sectional and cohort study in Southeast London.

Unmet needs for treatment in 102 individuals with brief and limited intermittent psychotic symptoms (BLIPS): implications for current clinical recommendations.

Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.

The Provision of Education and Employment Support At the Outreach and Support in South London (OASIS) Service for People at Clinical High Risk for Psychosis.

Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people.

Proportion of young people in the general population consulting general practitioners: Potential for mental health screening and prevention.

What is good mental health? A scoping review.

Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence).

Worldwide implementation of clinical services for the prevention of psychosis: The IEPA early intervention in mental health survey.

Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.

World/self ambivalence: A shared mechanism in different subsets of psychotic experiences? Linking symptoms with resting-state fMRI.

Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis.

The gut-microbiome as a target for the treatment of schizophrenia: A systematic review and meta-analysis of randomised controlled trials of add-on strategies.

Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study.

Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study.

Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.

Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit.